Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Cash & Equivalents (2020 - 2026)

Sotera Health has reported Cash & Equivalents over the past 6 years, most recently at $344.6 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 24.3% year-over-year to $344.6 million; the TTM value through Dec 2025 reached $344.6 million, up 24.3%, while the annual FY2025 figure was $344.6 million, 24.3% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $344.6 million at Sotera Health, up from $299.2 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $647.9 million in Q1 2023 and troughed at $106.9 million in Q4 2021.
  • A 5-year average of $256.5 million and a median of $261.9 million in 2023 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: soared 433.55% in 2023 and later tumbled 59.7% in 2024.
  • Year by year, Cash & Equivalents stood at $106.9 million in 2021, then skyrocketed by 269.65% to $395.2 million in 2022, then decreased by 25.0% to $296.4 million in 2023, then fell by 6.47% to $277.2 million in 2024, then increased by 24.3% to $344.6 million in 2025.
  • Business Quant data shows Cash & Equivalents for SHC at $344.6 million in Q4 2025, $299.2 million in Q3 2025, and $332.4 million in Q2 2025.